SCHEMBL4728358

SCHEMBL4728358

C[Si](C)(C)CCOCc1nc(S(=O)(=O)c2ccccc2)[nH]c1-c1ccc2cnccc2c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKT1 P31749 3/20 0.36
CDK2 P24941 2/20 0.36
DYRK3 O43781 1/20 0.36
ROCK2 O75116 1/20 0.36
PRKD3 O94806 1/20 0.36
MAP4K4 O95819 1/20 0.36
CDK1 P06493 1/20 0.36
ROS1 P08922 1/20 0.36
PIM1 P11309 1/20 0.36
PRKACA P17612 1/20 0.36
RPS6KB1 P23443 1/20 0.36
CLK2 P49760 1/20 0.36
GSK3B P49841 1/20 0.36
IRAK1 P51617 1/20 0.36
RPS6KA3 P51812 1/20 0.36
PRKX P51817 1/20 0.36
CDK5 Q00535 1/20 0.36
PRKCD Q05655 1/20 0.36
MAP4K2 Q12851 1/20 0.36
ROCK1 Q13464 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4895976 0.75 AKT1 (0.38) AKT1CDK2DYRK3ROCK2PRKD3
SCHEMBL8489958 0.75 FFAR2 (0.34) ALDH1A1
SCHEMBL8488040 0.69 HTT (0.35) ALDH1A1SMN1; SMN2TDP1
SCHEMBL8492036 0.69 ABCB1 (0.32) ALDH1A1
SCHEMBL8486725 0.66 ABCB1 (0.33) NAMPTKDM4EALDH1A1MAPK1
SCHEMBL8488050 0.65 FFAR2 (0.39)
SCHEMBL19476153 0.64 NAMPT (0.53) ROCK2ROCK1NAMPTCYP2C9
SCHEMBL25419075 0.60 DGAT1 (0.37) AKT1CDK2DYRK3ROCK2PRKD3
SCHEMBL30481298 0.60 DGAT1 (0.37) AKT1CDK2DYRK3ROCK2PRKD3
SCHEMBL6355545 0.59 CYP11B2 (0.61) AKT1CDK2CDC7CCNE1DBF4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008036308-A2 AMINO-SUBSTITUTED HETEROCYCLES, COMPOSITIONS THEREOF, AND METHODS OF TREATMENT THEREWITH SIGNAL PHARMACEUTICALS, LLC (US) 2008-03-27 WO disclosed